Once More with Feeling - Amgen Again Settles Allegations of Misbranding, But Why Bother?
The Latest Settlement Biotechnology giant Amgen has just reached another settlement of allegations that it unfairly, deceptively or misleadingly marketed its drug. Per the Los Angeles Times,Amgen Inc. has agreed to pay $71...
